FDA Approves Leqembi Drug for Alzheimer
The US Food and Drugs Administration approved Alzheimer drug Leqembi, the first drug to show efficacy in slowing down the progress of the disease.”Todays action is the first verification that a drug targeting the underlying disease process of Alzheimer…